{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:11:00Z","timestamp":1765296660766,"version":"3.46.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA282149"],"award-info":[{"award-number":["R01CA282149"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-09268-w","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:33:12Z","timestamp":1765290792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementing the NYU Electronic Patient Visit Assessment (ePVA)\u00a9 for head and neck cancer in rural and urban populations: a study protocol for a type 1 hybrid effectiveness-implementation clinical trial"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7011-4298","authenticated-orcid":false,"given":"Janet H.","family":"Van Cleave","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham A.","family":"Brody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dena","family":"Schulman-Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth S.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zujun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent J.","family":"Major","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher E.","family":"Lominska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica R.","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander N.","family":"Hanania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghia V.","family":"Tatlonghari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcely","family":"Tsikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Egleston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"9268_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"9268_CR2","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"9268_CR3","volume":"11","author":"A Barsouk","year":"2023","unstructured":"Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med Sci. 2023;11:42.","journal-title":"Med Sci"},{"key":"9268_CR4","unstructured":"Ratko TA, Douglas GW, de Souza JA, Belinson SE, Aronson N. Radiotherapy treatments for head and neck cancer update. Comparative Effectiveness Review No. 144. (Prepared by Blue Cross and Blue Shield Association Evidence-based Practice Center under Contract No. 290\u20132007\u201310058.) AHRQ Publication No. 15-EHC001-EF. Rockville, MD: Agency for Healthcare Research and Quality. 2014. www.effectivehealthcare.ahrq.gov\/reports\/final.cfm."},{"key":"9268_CR5","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/hed.26681","volume":"43","author":"B Ebersole","year":"2021","unstructured":"Ebersole B, McCarroll L, Ridge JA, Liu JC, Bauman J, Donnelly S, et al. Identification and management of late dysfunction in survivors of head and neck cancer: implementation and outcomes of an interdisciplinary quality of life (IQOL) clinic. Head Neck. 2021;43:2124\u201335.","journal-title":"Head Neck"},{"key":"9268_CR6","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1089\/jpm.2020.0656","volume":"24","author":"JR Bauman","year":"2021","unstructured":"Bauman JR, Panick JR, Galloway TJ, Ridge JA, Chwistek MA, Collins ME, et al. A pilot study of a collaborative palliative and oncology care intervention for patients with head and neck cancer. J Palliat Med. 2021;24:1673\u201381.","journal-title":"J Palliat Med"},{"key":"9268_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s40463-016-0175-x","volume":"45","author":"JM Melotek","year":"2016","unstructured":"Melotek JM, Cooper BT, Koshy M, Silverman JS, Spiotto MT. Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer. J Otolaryngol Head Neck Surg. 2016;45:62.","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"9268_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1188\/13.ONF.40-06AP","volume":"40","author":"H Mason","year":"2013","unstructured":"Mason H, DeRubeis MB, Foster JC, Taylor JMG, Worden FP. Outcomes evaluation of a weekly nurse practitioner-managed symptom management clinic for patients with head and neck cancer treated with chemoradiotherapy. Oncol Nurs Forum. 2013;40:581\u20136.","journal-title":"Oncol Nurs Forum"},{"key":"9268_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.oraloncology.2012.10.004","volume":"49","author":"C Xiao","year":"2013","unstructured":"Xiao C, Hanlon A, Zhang Q, Ang K, Rosenthal DI, Nguyen-Tan PF, et al. Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Oncol. 2013;49:360\u20136.","journal-title":"Oral Oncol"},{"key":"9268_CR10","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1002\/cncr.28672","volume":"120","author":"DI Rosenthal","year":"2014","unstructured":"Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, et al. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center symptom inventory-head and neck module. Cancer. 2014;120:1975\u201384.","journal-title":"Cancer"},{"key":"9268_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","volume":"318","author":"E Basch","year":"2017","unstructured":"Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318:197\u20138.","journal-title":"JAMA"},{"key":"9268_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/jama.2018.18085","volume":"321","author":"F Denis","year":"2019","unstructured":"Denis F, Basch E, Septans AL, Bennouna J, Urban T, Dueck AC, et al. Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA. 2019;321:306\u20137.","journal-title":"JAMA"},{"key":"9268_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34:557\u201365.","journal-title":"J Clin Oncol"},{"key":"9268_CR14","unstructured":"Centers for Medicare & Medicaid Services. Enhancing Oncology Model. 2022. https:\/\/innovation.cms.gov\/innovation-models\/enhancing-oncology-model. Accessed 19 Oct 2025."},{"key":"9268_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1200\/OP.22.00329","volume":"18","author":"A Chong","year":"2022","unstructured":"Chong A, Witherspoon E, Honig B, Ela E, Cavanagh H, Strawbridge L. Reflections on the Oncology Care Model and looking ahead to the Enhancing Oncology Model. JCO Oncol Pract. 2022;18:685\u201390.","journal-title":"JCO Oncol Pract"},{"key":"9268_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/jnci\/djac194","volume":"115","author":"TA Patel","year":"2023","unstructured":"Patel TA, Jain B, Parikh RB. The enhancing oncology model: leveraging improvement science to increase health equity in value-based care. J Natl Cancer Inst. 2023;115:125\u201330.","journal-title":"J Natl Cancer Inst"},{"key":"9268_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1200\/CCI.21.00063","volume":"5","author":"DA Patt","year":"2021","unstructured":"Patt DA, Wilfong L, Hudson KE, Patel A, Books H, Pearson B, et al. Implementation of electronic patient-reported outcomes for symptom monitoring in a large multi-site community oncology practice: dancing the Texas two-step through a pandemic. JCO Clin Cancer Inform. 2021;5:615\u201321.","journal-title":"JCO Clin Cancer Inform"},{"key":"9268_CR18","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.22.00187","volume":"7","author":"E Basch","year":"2023","unstructured":"Basch E, Rocque G, Mody G, Mullangi S, Patt D. Tenets for implementing electronic patient-reported outcomes for remote symptom monitoring during cancer treatment. JCO Clin Cancer Inform. 2023;7:e2200187.","journal-title":"JCO Clin Cancer Inform"},{"key":"9268_CR19","doi-asserted-by":"publisher","first-page":"e2100137","DOI":"10.1200\/CCI.21.00137","volume":"6","author":"MJ Hassett","year":"2022","unstructured":"Hassett MJ, Cronin C, Tsou TC, Wedge J, Bian J, Dizon DS, et al. eSyM: an electronic health record-integrated patient-reported outcomes-based cancer symptom management program used by six diverse health systems. JCO Clin Cancer Inform. 2022;6:e2100137.","journal-title":"JCO Clin Cancer Inform"},{"key":"9268_CR20","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/annonc\/mdv181","volume":"26","author":"D Howell","year":"2015","unstructured":"Howell D, Molloy S, Wilkinson K, Green E, Orchard K, Wang K, et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol. 2015;26:1846\u201358.","journal-title":"Ann Oncol"},{"key":"9268_CR21","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","volume":"32","author":"G Kotronoulas","year":"2014","unstructured":"Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014;32:1480\u2013501.","journal-title":"J Clin Oncol"},{"key":"9268_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/jmrs.421","volume":"68","author":"H Nguyen","year":"2021","unstructured":"Nguyen H, Butow P, Dhillon H, Sundaresan P. A review of the barriers to using patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) in routine cancer care. J Med Radiat Sci. 2021;68:186\u201395.","journal-title":"J Med Radiat Sci"},{"key":"9268_CR23","volume":"18","author":"L Dirven","year":"2022","unstructured":"Dirven L, Taphoorn MJB. Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients. Lancet Reg Health. 2022;18:100396.","journal-title":"Lancet Reg Health"},{"key":"9268_CR24","volume":"18","author":"AS Schuit","year":"2022","unstructured":"Schuit AS, Holtmaat K, Lissenberg-Witte BI, Eerenstein SEJ, Zijlstra JM, Eeltink C, et al. Efficacy of the eHealth application Oncokompas, facilitating incurably ill cancer patients to self-manage their palliative care needs: a randomized controlled trial. Lancet Reg Health. 2022;18:100390.","journal-title":"Lancet Reg Health"},{"key":"9268_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00012272-199703000-00003","volume":"19","author":"ER Lenz","year":"1997","unstructured":"Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. The middle-range theory of unpleasant symptoms: an update. ANS Adv Nurs Sci. 1997;19:14\u201327.","journal-title":"ANS Adv Nurs Sci"},{"key":"9268_CR26","doi-asserted-by":"publisher","DOI":"10.21037\/mhealth.2019.06.05","volume":"5","author":"JH Van Cleave","year":"2019","unstructured":"Van Cleave JH, Fu MR, Bennett AV, Persky MS, Li Z, Jacobson AS, et al. The development, usability, and reliability of the Electronic Patient Visit Assessment (ePVA) for head and neck cancer. Mhealth. 2019;5:21.","journal-title":"Mhealth"},{"key":"9268_CR27","doi-asserted-by":"publisher","DOI":"10.21037\/mhealth-19-250","volume":"7","author":"JH Van Cleave","year":"2021","unstructured":"Van Cleave JH, Fu MR, Bennett AV, Concert C, Riccobene A, Tran A, et al. The usefulness of the electronic patient visit assessment (ePVA)\u00a9 as a clinical support tool for real-time interventions in head and neck cancer. Mhealth. 2021;7:7.","journal-title":"Mhealth"},{"key":"9268_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/CR9.0000000000000051","volume":"4","author":"JH Van Cleave","year":"2024","unstructured":"Van Cleave JH, Concert C, Kamberi M, Zahriah E, Most A, Mojica J, et al. A preliminary validation of an optimal cutpoint in total number of patient-reported symptoms in head and neck cancer for effective alignment of clinical resources with patients\u2019 symptom burden. Cancer Care Research Online. 2024;4:e051.","journal-title":"Cancer Care Research Online"},{"key":"9268_CR29","first-page":"e43","volume":"50","author":"J Van Cleave","year":"2023","unstructured":"Van Cleave J. Implementing the NYU Electronic Patient Visit Assessment (ePVA) to improve patient outcomes in head and neck cancer. Oncol Nurs Forum. 2023;50:e43\u20134.","journal-title":"Oncol Nurs Forum"},{"key":"9268_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","volume":"50","author":"GM Curran","year":"2012","unstructured":"Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50:217\u201326.","journal-title":"Med Care"},{"key":"9268_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137.","journal-title":"Ann Intern Med"},{"key":"9268_CR32","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"key":"9268_CR33","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","volume":"89","author":"BC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89:1245\u201351.","journal-title":"Acad Med"},{"key":"9268_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081477","volume":"389","author":"AW Chan","year":"2025","unstructured":"Chan AW, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, et al. SPIRIT 2025 statement: updated guideline for protocols of randomised trials. BMJ. 2025;389:e081477.","journal-title":"BMJ"},{"key":"9268_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081660","volume":"389","author":"A Hr\u00f3bjartsson","year":"2025","unstructured":"Hr\u00f3bjartsson A, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, et al. SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials. BMJ. 2025;389:e081660.","journal-title":"BMJ"},{"key":"9268_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00194","volume":"8","author":"RE Glasgow","year":"2020","unstructured":"Glasgow RE, Battaglia C, McCreight M, Ayele RA, Rabin BA. Making implementation science more rapid: use of the RE-AIM framework for mid-course adaptations across five health services research projects in the Veterans Health Administration. Front Public Health. 2020;8:194.","journal-title":"Front Public Health"},{"key":"9268_CR37","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2021.789","volume":"5","author":"JS Holtrop","year":"2021","unstructured":"Holtrop JS, Estabrooks PA, Gaglio B, Harden SM, Kessler RS, King DK, et al. Understanding and applying the RE-AIM framework: clarifications and resources. J Clin Transl Sci. 2021;5:e126.","journal-title":"J Clin Transl Sci"},{"key":"9268_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2019.00064","volume":"7","author":"RE Glasgow","year":"2019","unstructured":"Glasgow RE, Harden SM, Gaglio B, Rabin B, Smith ML, Porter GC, et al. Re-aim planning and evaluation framework: adapting to new science and practice with a 20-year review. Front Public Health. 2019;7:64.","journal-title":"Front Public Health"},{"issue":"6","key":"9268_CR39","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.2105\/AJPH.2013.301299","volume":"103","author":"B Gaglio","year":"2013","unstructured":"Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013;103(6):e38-46.","journal-title":"Am J Public Health"},{"key":"9268_CR40","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","volume":"89","author":"RE Glasgow","year":"1999","unstructured":"Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89:1322\u20137.","journal-title":"Am J Public Health"},{"key":"9268_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform."},{"key":"9268_CR42","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"9268_CR43","doi-asserted-by":"publisher","unstructured":"Al-Mamgani A, de Ridder M, Navran A, Klop WM, de Boer JP, Tesselaar ME. The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma. Eur Arch Oto-Rhino-Laryngol. 2017;274(10):3757\u201365. https:\/\/doi.org\/10.1007\/s00405-017-4687-4.","DOI":"10.1007\/s00405-017-4687-4"},{"key":"9268_CR44","doi-asserted-by":"publisher","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376. https:\/\/doi.org\/10.1093\/jnci\/85.5.365.","DOI":"10.1093\/jnci\/85.5.365"},{"key":"9268_CR45","doi-asserted-by":"publisher","unstructured":"Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol. 1994;33(8):879\u201385. https:\/\/doi.org\/10.3109\/02841869409098450.","DOI":"10.3109\/02841869409098450"},{"key":"9268_CR46","doi-asserted-by":"publisher","unstructured":"Xiao W, Chan CWH, Fan Y, et al. Symptom clusters in patients with nasopharyngeal carcinoma during radiotherapy. Eur J Oncol Nurs. 2017;28:7\u201313. https:\/\/doi.org\/10.1016\/j.ejon.2017.02.004.","DOI":"10.1016\/j.ejon.2017.02.004"},{"key":"9268_CR47","doi-asserted-by":"publisher","unstructured":"Cramer JD, Johnson JT, Nilsen ML. Pain in head and neck cancer survivors: Prevalence, predictors, and quality-of-life impact. Otolaryngol - Head and Neck Surg (United States). 2018;159(5):853\u20138. https:\/\/doi.org\/10.1177\/0194599818783964.","DOI":"10.1177\/0194599818783964"},{"key":"9268_CR48","doi-asserted-by":"publisher","unstructured":"Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA: J Am Med Assoc. 1995;273(1):59\u201365. https:\/\/doi.org\/10.1001\/jama.273.1.59.","DOI":"10.1001\/jama.273.1.59"},{"key":"9268_CR49","doi-asserted-by":"publisher","unstructured":"Aarstad HJ, \u00d8sthus AA, Aarstad HH, Lybak S, Aarstad AKH. General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival. Eur Arch Oto-Rhino-Laryngol. 2018;275(1):207\u201317. https:\/\/doi.org\/10.1007\/s00405-017-4800-8.","DOI":"10.1007\/s00405-017-4800-8"},{"key":"9268_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/10447319509526110","volume":"7","author":"JR Lewis","year":"1995","unstructured":"Lewis JR. IBM computer usability satisfaction questionnaires: psychometric evaluation and instructions for use. Int J Hum Comput Interact. 1995;7:57\u201378.","journal-title":"Int J Hum Comput Interact"},{"key":"9268_CR51","doi-asserted-by":"publisher","unstructured":"Davis F. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly. 1989;13(3):319\u201340. https:\/\/doi.org\/10.2307\/249008.","DOI":"10.2307\/249008"},{"key":"9268_CR52","doi-asserted-by":"crossref","unstructured":"Venkatesh V, Davis FD. A theoretical extension of the technology acceptance model: Four longitudinal field studies. Manag Sci. 2000;46(2):186\u2013204.","DOI":"10.1287\/mnsc.46.2.186.11926"},{"key":"9268_CR53","doi-asserted-by":"publisher","unstructured":"Davis FD, Bagozzi RP, Warshaw PR. User acceptance of computer technology\u202f: A comparison of two theoretical models. Manag Sci. 1989;35(8):982\u20131003. https:\/\/doi.org\/10.1287\/mnsc.35.8.982.","DOI":"10.1287\/mnsc.35.8.982"},{"key":"9268_CR54","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2307\/2530245","volume":"35","author":"PC O\u2019Brien","year":"1979","unstructured":"O\u2019Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549\u201356.","journal-title":"Biometrics"},{"key":"9268_CR55","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","volume":"42","author":"LA Palinkas","year":"2015","unstructured":"Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42:533\u201344.","journal-title":"Adm Policy Ment Health"},{"key":"9268_CR56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cptl.2020.09.005","volume":"13","author":"MD Wolcott","year":"2021","unstructured":"Wolcott MD, Lobczowski NG. Using cognitive interviews and think-aloud protocols to understand thought processes. Curr Pharm Teach Learn. 2021;13:181\u20138.","journal-title":"Curr Pharm Teach Learn"},{"key":"9268_CR57","first-page":"85","volume":"27","author":"TE Raghunathan","year":"2001","unstructured":"Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol. 2001;27:85\u201395.","journal-title":"Surv Methodol"},{"key":"9268_CR58","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277\u201388.","journal-title":"Qual Health Res"},{"key":"9268_CR59","unstructured":"Creswell JW, Plano Clark VL. Designing and Conducting Mixed Methods Research. 2nd ed. Thousand Oaks, CA: Sage; 2011."},{"key":"9268_CR60","doi-asserted-by":"crossref","unstructured":"Curry L, Nunez-Smith M. Mixed methods in health sciences research: A practical primer. Thousand Oaks, CA: Sage; 2015.","DOI":"10.4135\/9781483390659"},{"key":"9268_CR61","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1370\/afm.1865","volume":"13","author":"TC Guetterman","year":"2015","unstructured":"Guetterman TC, Fetters MD, Creswell JW. Integrating quantitative and qualitative results in health science mixed methods research through joint displays. Ann Fam Med. 2015;13:554\u201361.","journal-title":"Ann Fam Med"},{"key":"9268_CR62","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.critrevonc.2006.07.005","volume":"62","author":"BA Murphy","year":"2007","unstructured":"Murphy BA, Ridner S, Wells N, Dietrich M. Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol. 2007;62:251\u201367.","journal-title":"Crit Rev Oncol Hematol"},{"key":"9268_CR63","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1200\/JCO.2015.61.4115","volume":"33","author":"J Ringash","year":"2015","unstructured":"Ringash J. Survivorship and quality of life in head and neck cancer. J Clin Oncol. 2015;33:3322\u20137.","journal-title":"J Clin Oncol"},{"key":"9268_CR64","first-page":"530","volume":"14","author":"SV Pakhomov","year":"2008","unstructured":"Pakhomov SV, Jacobsen SJ, Chute CG, Roger VL. Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care. 2008;14:530\u20139.","journal-title":"Am J Manag Care"},{"key":"9268_CR65","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/jamaoto.2016.0656","volume":"142","author":"AD Falchook","year":"2016","unstructured":"Falchook AD, Green R, Knowles ME, Amdur RJ, Mendenhall W, Hayes DN, et al. Comparison of patient- and practitioner-reported toxic effects associated with chemoradiotherapy for head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2016;142:517\u201323.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"9268_CR66","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMp1611252","volume":"376","author":"E Basch","year":"2017","unstructured":"Basch E. Patient-reported outcomes - harnessing patients\u2019 voices to improve clinical care. N Engl J Med. 2017;376:105\u20138.","journal-title":"N Engl J Med"},{"key":"9268_CR67","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1001\/jama.2022.9265","volume":"327","author":"E Basch","year":"2022","unstructured":"Basch E, Schrag D, Henson S, Jansen J, Ginos B, Stover AM, et al. Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. JAMA. 2022;327:2413\u201322.","journal-title":"JAMA"},{"key":"9268_CR68","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1056\/NEJMra1806949","volume":"381","author":"I Sim","year":"2019","unstructured":"Sim I. Mobile devices and health. N Engl J Med. 2019;381:956\u201368.","journal-title":"N Engl J Med"},{"key":"9268_CR69","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1200\/OP.23.00715","volume":"20","author":"L Eng","year":"2024","unstructured":"Eng L, Chan RJ, Chan A, Charalambous A, Darling HS, Grech L, et al. Perceived barriers toward patient-reported outcome implementation in cancer care: an international scoping survey. JCO Oncol Pract. 2024;20:816\u201326.","journal-title":"JCO Oncol Pract"},{"key":"9268_CR70","unstructured":"Pew Research Center. Mobile Fact Sheet. In: Fact Sheets: Tech Adoption Trends. 2024. https:\/\/www.pewresearch.org\/internet\/fact-sheet\/mobile\/. Accessed 19 Oct 2025."},{"key":"9268_CR71","unstructured":"U.S. Department of Health and Human Services. What is FHIR\u00ae? In: ONC\u2019s Cures Act Final Rule. The Office of the National Coordinator for Health Information Technology. https:\/\/www.healthit.gov\/curesrule\/. Accessed 10 Oct 2024."},{"key":"9268_CR72","doi-asserted-by":"crossref","unstructured":"HL7.org. HL7 FHIR Release 5. 2023. In: 2.1.20 Introducing HL7 FHIR. 2023. https:\/\/www.hl7.org\/fhir\/. Accessed 19 Oct 2025.","DOI":"10.4018\/JHMS.316144"},{"key":"9268_CR73","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/jamia\/ocv189","volume":"23","author":"JC Mandel","year":"2016","unstructured":"Mandel JC, Kreda DA, Mandl KD, Kohane IS, Ramoni RB. SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J Am Med Inform Assoc. 2016;23:899\u2013908.","journal-title":"J Am Med Inform Assoc"},{"key":"9268_CR74","unstructured":"National Cancer Institute Implementation Science. In: Division of Cancer Control & Population Science. 2025. https:\/\/cancercontrol.cancer.gov\/is. Accessed 19 Oct 2025."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09268-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09268-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09268-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:02:18Z","timestamp":1765296138000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09268-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9268"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09268-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol is approved by The University of Texas Health Science Center at Houston Committee for the Protection of Human Subjects (HSC-SN-23-0784 version 1.9, dated 10\/8\/25). The initial IRB approval and model consent to participate are submitted with this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The copyrights in the ePVA are owned by New York University (NYU). If NYU receives income from licensing the ePVA, then authors Janet H. Van Cleave and Kenneth S. Hu may receive a portion of the license income. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"563"}}